A Study To Taste Three New Types Of Crizotinib Formulation In Comparison Of An Oral Solution And To Measure The Amount Of Crizotinib In The Body After These Formulations Are Orally Given, Relative To Capsule Formulation

NCT02006277 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Crizotinib prototype microsphere 0.529 mg/mg
DRUG: crizotinib prototype microsphere 0.470 mg/mg
DRUG: crizotinib prototype microsphere 0.420 mg/mg
DRUG: crizotinib oral solution
DRUG: crizotinib prototype microsphere 0.529 mg/mg
DRUG: crizotinib prototype microsphere 0.470 mg/mg
DRUG: crizotinib prototype microsphere 0.420 mg/mg
DRUG: crizotinib capsule
DRUG: crizotinib oral solution

Sponsor

Pfizer